REFERENCES
- Chu T, D'Angio G J, Favara B E, Ladisch S, Nesbit M, Pritchard J. Histiocytosis syndromes in children. Lancet 1987; 1: 208–209, [CSA]
- Lichtenstein L. Histiocytosis X, integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Schüller-Christian disease as related manifestations of a single nosologic entity. Arch Patol 1953; 56: 84–102, [CSA]
- Langerhans P. Über die Nerven der menschlichen Haut. Virchows. Arch Abl B Pathol 1868; 44: 325–337, [CSA], [CROSSREF]
- de Graaf J H, Egeler R M. New insights into the patogenesis of Langerhans cell histiocytosis. Curr Opin Pediatr 1997; 9: 46–50, [PUBMED], [INFOTRIEVE], [CSA]
- Willman C L, Busque L, Griffith B B, et al. Langerhans'-cell histiocytosis (histiocytosis X)—a clonal proliferative disease. N Engl J Med 1994; 331: 154–160, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zelger B. Langerhans cell histiocytosis: a reactive or neoplastic disorder?. Med Pediatr Oncol 2001; 7: 543–544, [CSA], [CROSSREF]
- Favara B E, Feller A C, Pauli M, et al. Contemporary classification of histiocytosis disorders. Med Pediatr Oncol 1997; 39: 157–166, [CSA], [CROSSREF]
- Nezelof C, Basset F. Langerhans cell histiocytosis research: past, present, and future. Hematol Oncol Clin North Am 1998; 12: 385–406, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kusumakumary P, James F V, Chellam V G, Ratheesan K, Nair M K. Disseminated Langerhans cell histocytosis in children: treatment outcome. Am J Clin Oncol 1999; 22: 180–183, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kilborn T N, The J, Goodman T R. Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings. Clin Radiol 2003; 58: 269–278, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Howarth D M, Mullan B P, Wiseman G A, Wenger D E, Forstrom L A, Dunn W L. Bone scintigraphy evaluated in diagnosis and staging Langerhans' cell histiocytosis and related disorders. J Nucl Med 1996; 37: 1456–1460, [PUBMED], [INFOTRIEVE], [CSA]
- Chu T. Langerhans cell histiocytosis. Australas J Dermatol 2001; 42: 237–242, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001; 138: 728–734, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ladisch S. Langerhans histiocytosis. Curr Opin Hematol 1998; 5: 54–58, [PUBMED], [INFOTRIEVE], [CSA]
- Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-Study. Med Pediatr Oncol 2001; 37: 108–114, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nagarajan R, Neglia J, Ramsay N, Baker K S. Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation. J Pediatr Hematol Oncol 2001; 23: 629–632, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Suminoe A, Matsuzaki A, Hattori H, Ishii S, Hara T. Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2001; 23: 633–636, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zeller B, Storm-Mathisen I, Smevik B, Lie S O. Multisystem Langerhans-cell histiocytosis with life-threatening pulmonary involvement-good response to cyclosporine A. Med Pediatr Oncol 2000; 35: 438–442, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stine K C, Saylors R L, Wiliams L L, Becton D L. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol 1997; 329: 734–735, [CSA]
- Horwarth D M, Gilchrist G S, Mullan B P, Wiseman G A, Edmonson J H, Schomberg P J. Langerhans cell histiocytosis. Cancer 1999; 85: 2278–2290, [CSA], [CROSSREF]
- Lahey M E. Histicytosis X—an analysis of prognostic factors. J Pediatr 1975; 87: 184–189, [PUBMED], [INFOTRIEVE], [CSA]
- Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H. DAL-HX Study Group. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 2002; 39: 581–585, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Broadbent V, Gadner H, Komp D M, Ladisch S. Histiocytosis syndromes in children, II: approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Med Pediatr Oncol 1989; 17: 492–495, [PUBMED], [INFOTRIEVE], [CSA]
- Egeler R M, D'pAngio G J. Langerhans cell histiocytosis. J Pediatr 1995; 127: 1–11, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]